Dietary tributyrin supplementation in Parkinson’s disease: An open-label target engagement study

Jeffrey L.B. Bohnen, Stiven Roytman, Travis P. Wigstrom, Robert K. Vangel, Jaime E. Barr, Giulia Carli, Sean M. Parks, Hitasha Mittal, Claire Martino, Prabesh Kanel, Roger L. Albin, Nicolaas I. Bohnen

Open source

DOI
10.1016/j.neurot.2025.e00791
Published
2026-01
Container
Neurotherapeutics
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.neurot.2025.e00791,
  title = {Dietary tributyrin supplementation in Parkinson’s disease: An open-label target engagement study},
  author = {Jeffrey L.B. Bohnen and Stiven Roytman and Travis P. Wigstrom and Robert K. Vangel and Jaime E. Barr and Giulia Carli and Sean M. Parks and Hitasha Mittal and Claire Martino and Prabesh Kanel and Roger L. Albin and Nicolaas I. Bohnen},
  year = {2026},
  journal = {Neurotherapeutics},
  doi = {10.1016/j.neurot.2025.e00791},
  url = {https://doi.org/10.1016/j.neurot.2025.e00791}
}

RIS

TY  - JOUR
TI  - Dietary tributyrin supplementation in Parkinson’s disease: An open-label target engagement study
AU  - Jeffrey L.B. Bohnen
AU  - Stiven Roytman
AU  - Travis P. Wigstrom
AU  - Robert K. Vangel
AU  - Jaime E. Barr
AU  - Giulia Carli
AU  - Sean M. Parks
AU  - Hitasha Mittal
AU  - Claire Martino
AU  - Prabesh Kanel
AU  - Roger L. Albin
AU  - Nicolaas I. Bohnen
PY  - 2026
JO  - Neurotherapeutics
DO  - 10.1016/j.neurot.2025.e00791
UR  - https://doi.org/10.1016/j.neurot.2025.e00791
ER  - 

APA

Bohnen, J. L., Roytman, S., Wigstrom, T. P., Vangel, R. K., Barr, J. E., Carli, G., Parks, S. M., Mittal, H., Martino, C., Kanel, P., Albin, R. L., & Bohnen, N. I. (2026). Dietary tributyrin supplementation in Parkinson’s disease: An open-label target engagement study. Neurotherapeutics. https://doi.org/10.1016/j.neurot.2025.e00791

Source records